Accelr8 Extends Agreement for Evaluation of BACcel System | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accelr8 Technology has extended a deal for the evaluation of its BACcel system one month to July 31, it said after the close of the market on Thursday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.